Squarepoint’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-40,402
Closed -$127K 3465
2020
Q3
$127K Sell
40,402
-30,220
-43% -$96.5K ﹤0.01% 2231
2020
Q2
$206K Buy
+70,622
New +$223K ﹤0.01% 1816
2020
Q1
Sell
-113,986
Closed -$370K 2856
2019
Q4
$370K Sell
113,986
-150,636
-57% -$437K ﹤0.01% 1924
2019
Q3
$572K Buy
264,622
+113,602
+75% +$304K 0.01% 1542
2019
Q2
$474K Buy
151,020
+13,286
+10% +$43.1K ﹤0.01% 1701
2019
Q1
$512K Buy
137,734
+84,539
+159% +$285K 0.01% 1474
2018
Q4
$154K Sell
53,195
-32,348
-38% -$88.9K ﹤0.01% 1749
2018
Q3
$225K Sell
85,543
-74,532
-47% -$183K ﹤0.01% 1706
2018
Q2
$375K Buy
160,075
+45,375
+40% +$127K 0.01% 1288
2018
Q1
$337K Buy
114,700
+82,954
+261% +$226K 0.01% 1269
2017
Q4
$87K Buy
31,746
+8,532
+37% +$26.2K ﹤0.01% 1975
2017
Q3
$79K Buy
+23,214
New +$64.5K ﹤0.01% 1529
2017
Q1
Sell
-111,390
Closed -$236K 2206
2016
Q4
$236K Buy
111,390
+90,590
+436% +$253K 0.01% 1312
2016
Q3
$70K Buy
+20,800
New +$66K ﹤0.01% 969
2016
Q1
Sell
-49,000
Closed -$173K 1690
2015
Q4
$173K Buy
+49,000
New +$205K 0.02% 1036

Other funds holding PDLI